SynthesisDigestive diseases and sciences2026
Systematic Review: Evaluating the Prognostic Value of Granulomas in Crohn's Disease.
Synthesis in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsHistological differences are among the characteristics that divide Crohn's disease (CD) from ulcerative colitis. Granulomas are one feature known to develop in a subset of patients with CD, though their exact role in prognosis is relatively limited. Therefore, there is an unmet need to further understand the features that predict patterns in disease courses for people with CD.
methodsA comprehensive literature search was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Databases used for the search were EMBASE, PubMed, CINAHL, Scopus, and Web of Science. Two reviewers independently reviewed abstracts and full text for inclusion. Overall, 46 studies were included for data collection and quality assessment.
resultsThe 46 studies included 37 cohort analyses, four systematic reviews (three with meta-analysis), four cross-sectional studies, and one case-control report. Common exposure and outcome variables included age, disease location and behavior, clinical severity, medication utilization, and surgical requirement. There was considerable risk for bias in accordance with the Critical Appraisal Skills Programme tool, with only 26 studies having met ≥ 80% of high-quality assessment criteria. Varying relationships were observed between granulomas and clinical aspects of disease such as phenotype, severity, and medication utilization.
conclusionThis systematic review aimed to centralize the current literature and provide insight into the possible prognostic value of granulomas in CD. Several studies suggested clinical relevance; however, larger studies that adjust for confounders are needed to truly elucidate the underlying pathophysiology and significance of granulomatous CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.